Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexey Surnov

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Oncotarget|July 1, 2021
The formation of pre-effectors in the steady state opens a new perspective for cancer immunosurveillanceAlexey Surnov, Daniel Hawiger
Cell Systems|January 10, 2024
Single-cell sequencing analysis within biologically relevant dimensionsRobert Kousnetsov, Jessica Bourque, Alexey Surnov, et al.
Frontiers in Immunology|April 1, 2022
Role of Dynamic Actin Cytoskeleton Remodeling in Foxp3<sup>+</sup> Regulatory T Cell Development and Function: Implications for OsteoclastogenesisSebastian Dohnke, Stephanie Moehser, Alexey Surnov, et al.
Frontiers in Immunology|January 5, 2024
ILC2-mediated immune crosstalk in chronic (vascular) inflammationMaria Kral, Emiel P C van der Vorst, Alexey Surnov, et al.
Heliyon|November 22, 2021
Landscape of Hopx expression in cells of the immune systemJessica Bourque, Adeleye Opejin, Alexey Surnov, et al.
Cell Reports|November 25, 2020
A Two-Step Process of Effector Programming Governs CD4<sup>+</sup> T Cell Fate Determination Induced by Antigenic Activation in the Steady StateAdeleye Opejin, Alexey Surnov, Ziva Misulovin, et al.
Frontiers in Immunology|April 1, 2025
Nanoparticle platform preferentially targeting liver sinusoidal endothelial cells induces tolerance in CD4+ T cell-mediated disease modelsShu-Hung Wang, Isabelle Serr, Reinaldo Digigow, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Oncotarget|July 1, 2021
The formation of pre-effectors in the steady state opens a new perspective for cancer immunosurveillanceAlexey Surnov, Daniel Hawiger
Cell Systems|January 10, 2024
Single-cell sequencing analysis within biologically relevant dimensionsRobert Kousnetsov, Jessica Bourque, Alexey Surnov, et al.
Frontiers in Immunology|April 1, 2022
Role of Dynamic Actin Cytoskeleton Remodeling in Foxp3<sup>+</sup> Regulatory T Cell Development and Function: Implications for OsteoclastogenesisSebastian Dohnke, Stephanie Moehser, Alexey Surnov, et al.
Frontiers in Immunology|January 5, 2024
ILC2-mediated immune crosstalk in chronic (vascular) inflammationMaria Kral, Emiel P C van der Vorst, Alexey Surnov, et al.
Heliyon|November 22, 2021
Landscape of Hopx expression in cells of the immune systemJessica Bourque, Adeleye Opejin, Alexey Surnov, et al.
Cell Reports|November 25, 2020
A Two-Step Process of Effector Programming Governs CD4<sup>+</sup> T Cell Fate Determination Induced by Antigenic Activation in the Steady StateAdeleye Opejin, Alexey Surnov, Ziva Misulovin, et al.
Frontiers in Immunology|April 1, 2025
Nanoparticle platform preferentially targeting liver sinusoidal endothelial cells induces tolerance in CD4+ T cell-mediated disease modelsShu-Hung Wang, Isabelle Serr, Reinaldo Digigow, et al.
Pageof 1